Integrity, respect and transparency guide Aché’s relationship with all its stakeholders.
Even though it is a privately held company, our policies and guidelines are in line with best practices of corporate governance, and we have adopted internal control mechanisms and independent audit processes for rendering accounts.
Our governance structure encompasses the Board of Shareholders’ Representatives, the Board of Directors, Committees and the Executive Board, which seek to conduct activities with a focus on business sustainability and generating value for our stakeholders.
Comprising four shareholders and six independent members, Aché’s Administrative Council is responsible for establishing the directives that guide the Company’s strategy and its vision for the future. In periodic meetings, it follows and monitors the execution of initiatives arising from the Strategic Plan and the Company’s economic and financial performance. To accomplish that, the Council is supported by five committees: Strategy, Innovation, Digital Transformation, People & ESG, and Corporate Finance & Risk Management.
BOARD OF DIRECTORS
The CEO and the Executive Board conduct business in an integrated way and in line with the guidelines established by the Council of Administration. They are responsible for structuring and implementing action plans to achieve the objectives set in the Strategic Plan. The Board of Directors is formed by 22 members, with expertise on each business front, and is supported by eight committees: Business Unit Performance; Innovation; Operational Excellence; Portfolio; Technology; People, Culture & Sustainability; Financial Results; and Audit, Risk Management & Compliance.
Organizational structure that enables a customized management, developing strategies as per the specificity of each business: Prescription Division, comprising the Prescription and Specialty Care Business Units; and Consumer Health Division, comprising the OTC, Generics and Dermatology Business Units.